EUVIMEDSkopri EUVIMED
Systematische ÜbersichtMetaanalyseOpen access · CC BY 4.0

Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta‐Analysis of Clinical Studies

Alaa Safia iD, Uday Abd Elhadi, Shlomo Merchavy, Ramzy Batheesh, Naji Bathish

Journal of Cosmetic Dermatology · 2026

DOI: 10.1111/jocd.70655 ↗

At a glance

Systematische Übersicht in Journal of Cosmetic Dermatology, 2026. Written by Alaa Safia and 4 co-authors. Institution: Department of Otolaryngology, Ziv Medical Center, Safed, Israel. Major MEDLINE topics: Botulinum Toxins, Type A, Skin Aging, Cosmetic Techniques, Neuromuscular Agents. Cited 4 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Botulinum toxin type A (BoNT‐A) is widely recognized as the leading nonsurgical cosmetic treatment worldwide for diminishing dynamic wrinkles in the glabellar, forehead, and periorbital areas. While BoNT‐A is widely acknowledged for its effectiveness and popularity, there are notable inconsistencies in results, methodologies, and safety reporting across clinical studies, highlighting the necessity for the careful development of strong, evidence‐driven guidelines.

Objectives

This study aimed to compile and evaluate data from clinical research focusing on upper‐face BoNT‐A injections, specifically regarding safety outcomes, effectiveness, patient satisfaction, and response rates. This investigation concentrated on the outcomes of the clinical trials conducted.

Methods

This analysis includes prospective cohorts, randomized controlled trials, and observational studies that report on BoNT‐A cosmetic treatments specifically in the upper face area. A thorough examination of MEDLINE, EMBASE, Cochrane Library, and Web of Science studies was conducted, covering literature up to May 2025. The assessment included response rates, levels of patient satisfaction, and the extent of wrinkle reduction. The analysis employed a random‐effects model to produce combined estimates, followed by an assessment of heterogeneity utilizing τ 2 , I 2 , and Cochran's Q . Forest diagrams and Egger's test were utilized to evaluate publication bias and the effects of small studies when applicable.

Results

After the administration of BoNT‐A therapy, a notable decrease in the severity ratings of wrinkles was observed, as indicated by the synthesis of ten clinical trials examining this aspect (Cohen's d = 1.93; 95% CI: 1.60–2.25; p = 0.001). However, the data also revealed a considerable degree of variability ( I 2 = 90%). The findings indicated substantial variability in effect sizes related to patient satisfaction across four distinct trials (Cohen's d = 22.54; 95% CI: −2.07–47.15; p = 0.07), accompanied by significant heterogeneity ( I 2 = 99.9%) and potential indications of publication bias. The findings revealed significant variability ( I 2 = 100%) and wide prediction intervals, indicating substantial inconsistency and limited applicability of the response outcomes in future research. Analysis of five studies regarding response rates revealed a significant overall effect (Cohen's d = 34.30; 95% CI: 3.65–64.94; p = 0.28). The overall impact was determined to be noteworthy.

Conclusions

BoNT‐A injections contribute to a decrease in wrinkle severity and improve clinical results for rejuvenating the upper face. Research indicates notable variability and susceptibility to bias regarding patient satisfaction and response rates. The findings emphasize the necessity for subgroup analyses, enhanced reporting methodologies, and uniform outcome evaluations to identify factors contributing to variability in responses to BoNT‐A therapy. Trial Registration This study was conducted in accordance with PROSPERO guidelines

Subjects

MeSH terms (MEDLINE)

Botulinum Toxins, Type ASkin AgingCosmetic TechniquesNeuromuscular AgentsHumansPatient SatisfactionTreatment OutcomeRandomized Controlled Trials as TopicFaceForeheadObservational Studies as Topic

Author keywords

BoNT‐A injectionscosmetic injectionsheterogeneitypatient's satisfactionpublication biasresponse rateupper face aesthetics BoNT‐A therapywrinkle severity scale

Substances

Botulinum Toxins, Type ANeuromuscular Agents

Authors and institutions

  • Department of Otolaryngology, Ziv Medical Center, Safed, Israel.
  • Department of Dermatology, Rambam Health Care Campus, Haifa, Israel.
  • Department of Dermatology, Ziv Medical Center, Safed, Israel.

ORCID profiles: Alaa Safia

Cite

APA

Safia, A., Elhadi, U. A., Merchavy, S., Batheesh, R., & Bathish, N. (2026). Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta‐Analysis of Clinical Studies. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70655

Vancouver

Safia A, Elhadi UA, Merchavy S, Batheesh R, Bathish N. Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta‐Analysis of Clinical Studies. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70655

BibTeX
@article{Safia2026,
  author = {Safia, Alaa and Elhadi, Uday Abd and Merchavy, Shlomo and Batheesh, Ramzy and Bathish, Naji},
  title = {Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta‐Analysis of Clinical Studies},
  journal = {Journal of Cosmetic Dermatology},
  year = {2026},
  doi = {10.1111/jocd.70655}
}
Start for free →